1Kirby RS.The natural history of benign prostatic hyperplasia:what have we learned in the last decade? Urology,2000,56(5Suppl 1):3-6. 被引量：1
2Girman CJ.Population based studies of the epidemiology of benign prostatic hyperplasia.Br J Urol,1998,82(Suppl 1):34-43. 被引量：1
3Gjertson CK,Walmsley K,Kaplan SA.Benign prostatic hyperplasia:now we can begin to tailor treatment.Cleve Clin J Med,2004,71:857-865. 被引量：1
4Lepor H.Alpha blockers for the treatment of benign prostatic hyperplasia.Rev Urol,2007,9:181-190. 被引量：1
5O' Leafy MP.Treatment and pharmacologic management of BPH in the context of common comorbidities.Am J Manag Care,2006,12(5 Suppl):129-140. 被引量：1
6Tanaka Y,Masumori N,Itoh N,et al.Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.J Urol,2002,167:2492-2495. 被引量：1
7Roehrborn CG,Oesterling JE,Auerbach S,et al.The Hytrin Community Assessment Trial Study:a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostactic hyperplasia.Urology,1996,47:159-168. 被引量：1
9DiSilverio F. Use of terazosin in the medical treatment of be nign prostatic hyperplasia: experience in Italy. Br J Urol, 1992, 70:22- 26. 被引量：1
10Lepor H, Auerbach S, Puras Baez A, et al. A randomized muhicenter placebo controlled study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol, 1992, 148: 1467-1474. 被引量：1
3Shah HN, Hegde SS, Shah JN, et al. Simultaneous transurethral cys-tolithotripsy with holmium laser enucleation of the prostate : a prospective feasibility study and review of literature [J]. BJU Int, 2007,99(3 ):595 - 600. 被引量：1
4Rowhrborm CG, McConnell JD. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia [ M ]. PA: W. B, Saun- ders Company, 2002 : 1 297 - 1 330. 被引量：1
5Hutchisona A, Farmer R, Verhamme K, et al. Tre efficacy of drug for the treatment, LUTS LBPA a, study in 6 European [ J ]. Eur Urol, 2007,5 1 ( 1 ) : 207 - 215. 被引量：1
6Fourcade RO, Th6ret N, Tai'ebc, et al. Profile and management of Patients treated for the first time for lower urinary tract symptoms/benign Prostatic hyperplasia in four European countries [ J ]. BJU Int, 2008, 101 ( 9 ) : 1 111-1 118. 被引量：1
8Higgins J, Green S. Cochrane handbook for systematic reviews of interven- tions. Version 5.1.0 Updated March 2011 [ EB/OL] . http ://www. cochrane, org/training/cochrane - handbook. 被引量：1
9Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta - adrenoceptor subtypes and their functional roles in hu- man normal and obstructed bladders[J]. J Urol, 2003, 170(2 Pt 1): 649 - 653. 被引量：1
